Gb Sciences Stock Current Valuation
| GBLX Stock | USD 0.01 0.00 0.00% |
Valuation analysis of GB Sciences helps investors to measure GB Sciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that GB Sciences' price fluctuation is very steady at this time. Calculation of the real value of GB Sciences is based on 3 months time horizon. Increasing GB Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for GB Sciences is useful when determining the fair value of the GBLX pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of GB Sciences. Since GB Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GBLX Pink Sheet. However, GB Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.01 | Real 0.0084 | Hype 0.01 |
The real value of GBLX Pink Sheet, also known as its intrinsic value, is the underlying worth of GB Sciences Company, which is reflected in its stock price. It is based on GB Sciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of GB Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GB Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GB Sciences helps investors to forecast how GBLX pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GB Sciences more accurately as focusing exclusively on GB Sciences' fundamentals will not take into account other important factors: GB Sciences Company Current Valuation Analysis
GB Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GB Sciences Current Valuation | 10.19 M |
Most of GB Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GB Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GB Sciences has a Current Valuation of 10.19 M. This is 99.93% lower than that of the Healthcare sector and 99.78% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
GBLX Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GB Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GB Sciences could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics of similar companies.GB Sciences is currently under evaluation in current valuation category among related companies.
GBLX Fundamentals
| Return On Equity | -50.98 | |||
| Return On Asset | -0.21 | |||
| Current Valuation | 10.19 M | |||
| Shares Outstanding | 379.21 M | |||
| Shares Owned By Insiders | 13.08 % | |||
| Price To Earning | 4.04 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 1.91 X | |||
| Gross Profit | (881.46 K) | |||
| EBITDA | 398.73 K | |||
| Net Income | (530.87 K) | |||
| Cash And Equivalents | 53.96 K | |||
| Total Debt | 397.31 K | |||
| Debt To Equity | 1.07 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.87 M) | |||
| Beta | 0.56 | |||
| Market Capitalization | 8.21 M | |||
| Total Asset | 2.55 M | |||
| Retained Earnings | (78.28 M) | |||
| Working Capital | 881 K | |||
| Current Asset | 2.2 M | |||
| Current Liabilities | 1.32 M | |||
| Z Score | -30.0 | |||
| Net Asset | 2.55 M |
About GB Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GB Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GB Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GB Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GB Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for GBLX Pink Sheet analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |